In a small study, patients generally accepted AI-drafted messages for routine communication. Perceptions about message ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
The AI juggernaut is all-in on the healthcare industry, launching three new products in the last six months. But it needs to ...
A diabetes drug could help lower the risk of heart failure in certain patients. A new study published in Nature Medicine analyzed how SGLT2 inhibitor dapagliflozin, a medication used to treat type 2 ...
After a decade of cognitive and functional decline, an 80-year-old patient with advanced Alzheimer’s disease showed remarkable signs of progress. All it took was a single dose of an experimental ...
A new report argues that speeding up Food and Drug Administration reviews could unlock trillions of dollars in economic value and get lifesaving treatments to patients faster. "It takes about a decade ...
Effective risk stratification in cancer survivorship requires handling longitudinal data characterized by multimodal inputs, irregular follow-up, and recurrent clinical events. This study evaluated ...
Two patients developed choroidal lymphoid hyperplasia associated with vision loss after starting treatment with the GLP-1 receptor agonist dulaglutide. Visual acuity and systemic lymphadenopathy ...
A French woman who tested positive for hantavirus after disembarking from the virus-stricken cruise ship is now in critical condition after doctors initially dismissed her symptoms as anxiety. The ...
WASHINGTON — The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results